21 – 30 of 37
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
A factor analytic approach to symptom patterns in dementia.
2010) In International Journal of Alzheimer's Disease(
- Contribution to journal › Article
- 2008
-
Mark
Glial Progenitor-Like Phenotype in Low-Grade Glioma and Enhanced CD133-Expression and Neuronal Lineage Differentiation Potential in High-Grade Glioma
(
- Contribution to journal › Article
-
Mark
Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma.
2008) 8th Congress of the European-Association-for-Neuro-Oncology (EANO) In Neuro-Oncology 10(6). p.1107-1107(
- Contribution to journal › Published meeting abstract
-
Mark
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.
(
- Contribution to journal › Article
- 2007
-
Mark
CD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cells
(
- Contribution to journal › Article
-
Mark
Microarray analysis of gliomas reveals chromosomal position-associated gene expression patterns and identifies potential immunotherapy targets.
(
- Contribution to journal › Article
-
Mark
Genetic intratumour heterogeneity in high-grade brain tumours is associated with telomere-dependent mitotic instability.
(
- Contribution to journal › Article
-
Mark
Neuroblastomas and medulloblastomas exhibit more Coxsackie adenovirus receptor expression than gliomas and other brain tumors.
(
- Contribution to journal › Article
- 2006
-
Mark
Dynamic Susceptibility Contrast-Enhanced Perfusion Magnetic Resonance (MR) Imaging Combined with Contrast-Enhanced MR Imaging in the Follow-up of Immunogene-Treated Glioblastoma Multiforme.
(
- Contribution to journal › Article